Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RIGL Rigel Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $46.64 +4.9% | $15.06 -2.0% |
| StockIQ Score | 70B Strong Risk: Medium | 35F Weak Risk: High |
| Technical | 65B- | 13F |
| Fundamental | 83A- | 35F |
| Growth | 74B | 50C- |
| Fair Value | 55C | 38F |
| News | 86A | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 62C+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Rigel Pharmaceuticals (RIGL) outperforms Ascentage Pharma (AAPG) across all categories. Its investor score (75 vs. 37), technical score (87 vs. 18), and fundamental score (83 vs. 35) are significantly higher, reflecting stronger market confidence and underlying strength. Only growth (74 vs. 50) and valuation (55 vs. 38) show closer—but still better—numbers for RIGL. The "STRONG" rating further supports its overall superiority.